Research Pharmaceutical Services, Inc., based in Fort Washington, Pennsylvania, is a leading global provider of outsourced, clinical research services to major pharmaceutical and biotechnology companies. Founded in 1998 by CEO Daniel M. Perlman, RPS created the industry’s first “embedded” solution, which allows customers to outsource entire clinical research functions to RPS, whose employees become integrated into customers’ organizations on a long-term basis. This innovative model enables biopharmaceutical companies to maintain oversight of their clinical trials, while reducing cost, improving quality and accelerating drug development processes. Each RPS program is customized to meet the unique needs of small, medium and large biopharmaceutical companies.
Warburg Pincus completed its acquisition of RPS in early 2011, and has since supported the company in executing its growth strategy and in strengthening its Board of Directors.
Back to Previous Page